Laboratory of Evolutionary Anthropology and Health, Binghamton University, Binghamton, New York, United States of America.
PLoS One. 2012;7(1):e30213. doi: 10.1371/journal.pone.0030213. Epub 2012 Jan 17.
Nearly one million deaths are attributed to malaria every year. Recent reports of multi-drug treatment failure of falciparum malaria underscore the need to understand the molecular basis of drug resistance. Multiple mutations in the Plasmodium falciparum chloroquine resistance transporter (pfcrt) are involved in chloroquine resistance, but the evolution of complex haplotypes is not yet well understood. Using over 4,500 archival human serum specimens collected from 19 Pacific populations between 1959 and 1979, the period including and just prior to the appearance of chloroquine treatment failure in the Pacific, we PCR-amplified and sequenced a portion of the pfcrt exon 2 from 771 P. falciparum-infected individuals to explore the spatial and temporal variation in falciparum malaria prevalence and the evolution of chloroquine resistance. In the Pacific, the prevalence of P. falciparum varied considerably across ecological zones. On the island of New Guinea, the decreases in prevalence of P. falciparum in coastal, high-transmission areas over time were contrasted by the increase in prevalence during the same period in the highlands, where transmission was intermittent. We found 78 unique pfcrt haplotypes consisting of 34 amino acid substitutions and 28 synonymous mutations. More importantly, two pfcrt mutations (N75D and K76T) implicated in chloroquine resistance were present in parasites from New Hebrides (now Vanuatu) eight years before the first report of treatment failure. Our results also revealed unexpectedly high levels of genetic diversity in pfcrt exon 2 prior to the historical chloroquine resistance selective sweep, particularly in areas where disease burden was relatively low. In the Pacific, parasite genetic isolation, as well as host acquired immune status and genetic resistance to malaria, were important contributors to the evolution of chloroquine resistance in P. falciparum.
每年有近 100 万人死于疟疾。最近有报道称恶性疟原虫对多种药物的治疗失败,这突显了了解药物耐药性分子基础的必要性。恶性疟原虫氯喹耐药转运蛋白(pfcrt)的多个突变与氯喹耐药有关,但复杂单倍型的进化尚不完全清楚。利用 1959 年至 1979 年间在太平洋地区的 19 个人群中收集的超过 4500 份存档人类血清标本,包括在太平洋地区出现氯喹治疗失败之前和之后的时间段,我们从 771 名感染恶性疟原虫的个体中 PCR 扩增并测序了 pfcrt 外显子 2 的一部分,以探索恶性疟原虫患病率的时空变化和氯喹耐药的演变。在太平洋地区,恶性疟原虫的流行率在不同生态区差异很大。在新几内亚岛上,随着时间的推移,沿海高传播地区恶性疟原虫的流行率下降,而同期高地的流行率上升,高地的传播呈间歇性。我们发现了 78 个独特的 pfcrt 单倍型,由 34 个氨基酸取代和 28 个同义突变组成。更重要的是,在新赫布里底群岛(现称瓦努阿图)的寄生虫中发现了两种与氯喹耐药相关的 pfcrt 突变(N75D 和 K76T),这两种突变发生在首次报告治疗失败的八年前。我们的研究结果还揭示了在历史上氯喹耐药性选择清除之前,pfcrt 外显子 2 中存在异常高的遗传多样性,特别是在疾病负担相对较低的地区。在太平洋地区,寄生虫遗传隔离以及宿主获得性免疫状态和对疟疾的遗传抗性是恶性疟原虫氯喹耐药进化的重要因素。